Indication
Polyvascular Disease
1 clinical trial
2 products
Clinical trial
Randomized Comparison of Efficacy and Safety of High-intensity Rosuvastatin/Ezetimibe Combination Versus Treat-to-target Rosuvastatin Monotherapy for Patients With Peripheral Artery or Polyvascular Disease (CARE-PVD Trial)Status: Not yet recruiting, Estimated PCD: 2026-05-06
Product
Rosuvastatin